MGMT and non-small cell lung carcinoma: We show that TMZ–POH inhibits MGMT dependent on proteasomal pathway and this inhibition is a significant factor in its toxic effect in NSCLC cells, thus proposing TMZ–POH as a potential therapeutic candidate for NSCLC.